Page last updated: 2024-09-03

n(6)-2-(4-amino-3-iodophenyl)ethyladenosine and n(6)-cyclopentyladenosine

n(6)-2-(4-amino-3-iodophenyl)ethyladenosine has been researched along with n(6)-cyclopentyladenosine in 1 studies

Compound Research Comparison

Studies
(n(6)-2-(4-amino-3-iodophenyl)ethyladenosine)
Trials
(n(6)-2-(4-amino-3-iodophenyl)ethyladenosine)
Recent Studies (post-2010)
(n(6)-2-(4-amino-3-iodophenyl)ethyladenosine)
Studies
(n(6)-cyclopentyladenosine)
Trials
(n(6)-cyclopentyladenosine)
Recent Studies (post-2010) (n(6)-cyclopentyladenosine)
600605062

Protein Interaction Comparison

ProteinTaxonomyn(6)-2-(4-amino-3-iodophenyl)ethyladenosine (IC50)n(6)-cyclopentyladenosine (IC50)
Adenosine receptor A1Rattus norvegicus (Norway rat)0.2256
Adenosine receptor A2bRattus norvegicus (Norway rat)1.16
Adenosine receptor A1Homo sapiens (human)0.0027
Adenosine receptor A2aRattus norvegicus (Norway rat)1.16

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bourgoin, S; Cesselin, F; Hamon, M; Mauborgne, A; PoliƩnor, H1

Other Studies

1 other study(ies) available for n(6)-2-(4-amino-3-iodophenyl)ethyladenosine and n(6)-cyclopentyladenosine

ArticleYear
Adenosine receptor-mediated control of in vitro release of pain-related neuropeptides from the rat spinal cord.
    European journal of pharmacology, 2002, Apr-19, Volume: 441, Issue:1-2

    Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Calcitonin Gene-Related Peptide; Cholecystokinin; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Neuropeptides; Pain; Phenethylamines; Potassium; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Spinal Cord; Substance P; Xanthines

2002